Cedars-Sinai Cancer investigators have developed a new nanotechnology-based test that can detect and profile prostate cancers-;even in microscopic amounts. Their work, published in the peer-reviewed journal nanotoday, suggests that this “liquid biopsy” test could spare many patients unnecessary treatment-related side effects, directing them instead to effective therapies that could prolong their lives.
“This research will revolutionize the liquid biopsy in prostate cancer,” said Edwin Posadas, MD, medical director of the Urologic Oncology Program and co-director of the Experimental Therapeutics Program in Cedars-Sinai Cancer. “The test is fast, minimally invasive and cost-effective, and opens up a new suite of tools that will help us optimize treatment and quality of life for prostate cancer patients.”
Cancer of the prostate, a walnut-sized gland just below the bladder, is the most common cancer and second-leading cause of cancer death among U.S. men.
The test developed by Posadas and co-investigators isolates and characterizes extracellular vesicles, also called EVs, from blood samples. EVs are microscopic packets of protein and genetic material that are shed by cells. The EV Digital Scoring Assay can pull these EV packets from the blood with unprecedented efficiency and analyze them in a manner that is faster than any currently available test.
The investigators tested blood samples from 40 patients with prostate cancer and found that the test was able to distinguish cancer localized to the prostate from cancer that had spread to other parts of the body.
Posadas envisions this test being used to help patients who have their prostate gland removed and later experience a rise in levels of prostate-specific antigen (PSA) in their blood. This happens in about 30% of post-surgical patients, and elevated PSA levels can indicate cancer recurrence.
If a remnant of the cancer has been left behind in the prostate bed, where the prostate gland once was, Posadas said focused radiation therapy can cure the disease or delay progression. But that treatment is not without risks.
“The bladder and rectum are near the prostate bed and can be damaged during the course of radiation therapy,” Posadas said. “The risk is only worth it if a man is going to benefit.”
If microscopic cancer deposits have spread outside the prostate area, focused radiation treatment will not prevent disease progression. These deposits, called micro-metastases, are not always detectable, even via the most advanced imaging, but investigators were able to detect them using the EV test.
“This would allow many patients to avoid the potential harms of radiation that isn’t targeting their disease, and instead receive systemic therapy that could slow disease progression,” Posadas said.
In retrospective case studies, investigators tested blood samples taken over time from three prostate cancer patients, including one patient who had undergone focused radiation treatments.
“At the time he was being treated, I was concerned that he was not benefiting,” Posadas said. “And the test results mirrored his clinical behavior and showed that, indeed, the treatments were not effective because he had micro-metastatic disease.”
The test is the latest in a yearslong series of Cedars-Sinai Cancer breakthroughs involving EVs. Posadas said that it could also be adapted to guide treatment as prostate cancer therapies become more targeted at the molecular level, ultimately extending patients’ lives. Posadas and his team of investigators are now working to further refine the test so that it can be studied in greater detail.
“This type of liquid biopsy, coupled with innovations such as our Molecular Twin initiative, is key to next-generation precision medicine that represents the newest frontier in cancer treatment,” said Dan Theodorescu, MD, PhD, director of Cedars-Sinai Cancer and the PHASE ONE Distinguished Chair. “And the type of progress we are making is only possible at an institution such as Cedars-Sinai Cancer, where we have patients, clinicians, scientists and creative engineering minds converging as one unit to address the most challenging problems in cancer.”
Posadas and the team aim to work with local and national partners and hope to see the test come into wide clinical practice in the near future.
News
Ethics in Nanomedicine: Key Issues and Principles
Nanomedicine, a branch of nanotechnology, is revolutionizing healthcare by enabling the manipulation of materials at the nanoscale to diagnose, treat, and prevent diseases. Unlike traditional treatments, nanoparticles (NPs) are highly precise in targeting diseased [...]
A call for robust H5N1 influenza preparedness and response
As the global threat of H5N1 influenza looms with outbreaks across species and continents including the U.S., three international vaccine and public health experts say it is time to fully resource and support a [...]
Mucosal COVID-19 boosters outperform mRNA shots in preventing upper airway infections
In a recent study published in Nature Immunology, a team of researchers from the United States used non-human primate models to compare the protection conferred by an intramuscular booster dose of the bivalent messenger ribonucleic acid [...]
How Space Travel Really Changes Astronauts – From the Inside Out
International team reveals previously unknown effects on physiology that could shape the future of long-duration space missions. Researchers have discovered significant changes in the gut microbiome due to spaceflight, which affects host physiology and [...]
Breakthrough in blood stem cell development offers hope for leukemia and bone marrow failure
Melbourne researchers have made a world first breakthrough into creating blood stem cells that closely resemble those in the human body. And the discovery could soon lead to personalized treatments for children with leukemia [...]
Scientists Develop Game-Changing Needle-Free COVID-19 Intranasal Vaccine
A new mucosal COVID-19 vaccine poised to revolutionize the delivery process is especially beneficial for those with a fear of needles. A next-generation COVID-19 mucosal vaccine is set to be a game-changer not only when delivering [...]
Scientists Develop All-in-One Solution To Catch and Destroy “Forever Chemicals”
A new water treatment system developed by UBC researchers efficiently removes and destroys PFAS pollutants using a dual-action catalyst, offering a sustainable and cost-effective solution for water purification challenges. Chemical engineers at the University of [...]
New method accelerates drug discovery from years to months
Researchers from the University of Cincinnati College of Medicine and Cincinnati Children's Hospital have found a new method to increase both speed and success rates in drug discovery. The study, published Aug. 30 in [...]
A new smart mask analyzes your breath to monitor your health
Your breath can give away a lot about you. Each exhalation contains all sorts of compounds, including possible biomarkers for disease or lung conditions, that could give doctors a valuable insight into your health. [...]
Study reveals the role of blood clotting in COVID-19
In a study that reshapes what we know about COVID-19 and its most perplexing symptoms, scientists have discovered that the blood coagulation protein fibrin causes the unusual clotting and inflammation that have become hallmarks [...]
A Novel Cancer Vaccine Combining Nano-11 and ADU-S100
In a recent article published in npj Vaccines, researchers detailed the development of a novel cancer vaccine that combines a plant-derived nanoparticle adjuvant, Nano-11, with a clinically tested STING agonist, ADU-S100. The primary objective was [...]
AI spots cancer and viral infections with nanoscale precision
Researchers have developed an artificial intelligence which can differentiate cancer cells from normal cells, as well as detect the very early stages of viral infection inside cells. The findings, published today in a study [...]
Tiny shards of plastic are increasingly infiltrating our brains, study says
Human brain samples collected at autopsy in early 2024 contained more tiny shards of plastic than samples collected eight years prior, according to a preprint posted online in May. A preprint is a study which has not yet [...]
Scientists Have Discovered Strange DNA in Our Brains – and It Could Be Shortening Our Lives
According to the research, these mitochondrial DNA insertions could be linked to early death. Mitochondria in brain cells frequently insert their DNA into the nucleus, potentially impacting lifespan, as those with more insertions were found to [...]
Watch Out After a Hospital Stay: You Could Be Exposing Your Family to Superbugs
Research indicates hospitals contribute to the local spread of antibiotic-resistant infections. A recent study published in the journal Infection Control & Hospital Epidemiology by the Society for Healthcare Epidemiology of America suggests that family members of [...]
Molecular Trickery: How COVID-19 Silently Sabotages the Human Immune System
Researchers have discovered that SARS-CoV-2 manipulates the human immune system by forcing cells to produce non-functional proteins, hindering the body’s antiviral defenses. This groundbreaking study by teams from prestigious Brazilian universities highlights potential targets for new COVID-19 treatments, [...]